Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide vs duloxetine for chemotherapy-induced polyneuropathy pain
2020-001285-11Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Lacosamide with Duloxetine (2 arms). Primary endpoint: Pain relief. Started Nov 2020; status: active.
02
Drugs
lacosamideduloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on 2020-001285-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001285-11.